drugset / Trial / NCT05277311
Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to determine if LongShengZhi Capsule is effective and safe in patients with ischemic stroke in comparison to placebo. This trial is a prospective, multicenter, randomized, placebo-controlled, double-blinded, parallel-group, superiority trial.
Timeline
- Start
- 2022-05-01
- Primary completion
- 2023-12-31
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LongShengZhi | Unknown | — | Oral |